VGI Health Technology (XNEC:VTL) Days Sales Outstanding : 0.00 (As of . 20)

View and export this data going back to 2021. Start your Free Trial

What is VGI Health Technology Days Sales Outstanding?

VGI Health Technology's average Accounts Receivable for the six months ended in . 20 was A$0.00 Mil. VGI Health Technology's Revenue for the six months ended in . 20 was A$0.00 Mil.

The historical rank and industry rank for VGI Health Technology's Days Sales Outstanding or its related term are showing as below:

XNEC:VTL's Days Sales Outstanding is not ranked ^*
in the Biotechnology industry.
Industry Median: 72.665
* Ranked among companies with meaningful Days Sales Outstanding only.

VGI Health Technology's Days Sales Outstanding stayed the same from . 20 (0.00) to . 20 (0.00).

VGI Health Technology Days Sales Outstanding Historical Data

The historical data trend for VGI Health Technology's Days Sales Outstanding can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

VGI Health Technology Days Sales Outstanding Chart

VGI Health Technology Annual Data

Trend

Days Sales Outstanding

VGI Health Technology Semi-Annual Data

Days Sales Outstanding

Competitive Comparison of VGI Health Technology's Days Sales Outstanding

For the Biotechnology subindustry, VGI Health Technology's Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

VGI Health Technology's Days Sales Outstanding Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, VGI Health Technology's Days Sales Outstanding distribution charts can be found below:

* The bar in red indicates where VGI Health Technology's Days Sales Outstanding falls into.

VGI Health Technology Days Sales Outstanding Calculation

Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Accounts Receivable can be measured by Days Sales Outstanding.

VGI Health Technology's Days Sales Outstanding for the fiscal year that ended in . 20 is calculated as

	Days Sales Outstanding (A: . 20 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: . 20 )	+	Accounts Receivable (A: . 20 ))	/	count )	/	Revenue (A: . 20 )	*	Days in Period
=	( (	+	)	/	1 )	/		*	365
=	0					/		*	365
=	N/A

VGI Health Technology's Days Sales Outstanding for the quarter that ended in . 20 is calculated as:

	Days Sales Outstanding (Q: . 20 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: . 20 )	+	Accounts Receivable (A: . 20 ))	/	count )	/	Revenue (A: . 20 )	*	Days in Period
=	( (	+	)	/	1 )	/		*	365 / 2
=	0					/		*	365 / 2
=	N/A

VGI Health Technology (XNEC:VTL) Days Sales Outstanding Explanation

For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.

VGI Health Technology Days Sales Outstanding Related Terms

Thank you for viewing the detailed overview of VGI Health Technology's Days Sales Outstanding provided by GuruFocus.com. Please click on the following links to see related term pages.

VGI Health Technology (XNEC:VTL) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » VGI Health Technology Ltd (XNEC:VTL) » Definitions » Days Sales Outstanding

Comparable Companies

Traded in Other Exchanges

N/A

Address

19 Martin Place, Level 45, Suite 03, Sydney, NSW, AUS, 2003

Website

https://www.vgiht.com

VGI Health Technology Ltd develops and commercializes evidence-based nutraceuticals and pharmaceuticals. It has two evidence-based nutraceutical products ready for commercial launch in the US as well as a therapeutic drug development program. The nE1-Heart targets maintenance of heart health - tocotrienols have a similar mode of action (inhibition of HMCG CoA biosynthesis) as statins, the Gold Standard for treatment of hyperlipidaemia; and nE1-Eliteth that reduces Delayed Onset Muscle Soreness, improves muscle recovery after exercise, exercise endurance and maintenance of peak muscle power.

VGI Health Technology (XNEC:VTL) Headlines

No Headlines